Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer

Kenneth Hoyt, Marshall Mahoney, Anna G. Sorace

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2 Citations (Scopus)

Abstract

This article evaluated volumetric molecular ultrasound (US) imaging with multi-targeted microbubble (MB) contrast agents for detection of angiogenic imaging biomarkers in a preclinical cancer model. Imaging was performed using a modified US system (Ultrasonix Medical Corp) equipped with a 4-dimensional (4D) transducer. Image processing software separated the US signal originating from intravascular MBs that were bound to the overexpressed targets from the freely circulating and unattached contrast agent. Molecular US imaging using targeted MBs was compared to results obtained using non-specific control MBs in the same prostate-cancer bearing mouse. Molecular US signals were significantly higher when imaging the targeted MBs versus imaging of control contrast agent (p < 0.001). Specifically, it was found that molecular US imaging of the targeted MB contrast agent produced a considerable mean intratumoral enhancement of 19.5 ± 2.2 dB. A significant inverse correlation was found between the molecular US signal and fractional tumor enhancement (ρ = -0.56, p = 0.02). This suggests that as the spatial distribution of the molecular US signal increases, the average intensity of the intratumoral reporter signal decreases. This finding could identify when the neovascularity is inadequate to meet the metabolic demands of the tumor, creating a strong angiogenic response. This high angiogenic response is typically found in aggressive cancers and during early stages of tumor growth. Therefore, molecular US imaging may improve US for the early detection of cancer and help distinguish indolent from aggressive disease.

Original languageEnglish (US)
Title of host publicationIEEE International Ultrasonics Symposium, IUS
PublisherIEEE Computer Society
Pages1160-1163
Number of pages4
ISBN (Electronic)9781479970490
DOIs
StatePublished - Jan 1 2014
Event2014 IEEE International Ultrasonics Symposium, IUS 2014 - Chicago, United States
Duration: Sep 3 2014Sep 6 2014

Other

Other2014 IEEE International Ultrasonics Symposium, IUS 2014
CountryUnited States
CityChicago
Period9/3/149/6/14

Fingerprint

angiogenesis
animal models
tumors
cancer
augmentation
biomarkers
mice
image processing
spatial distribution
transducers
computer programs

Keywords

  • angiogenesis
  • contrast agent
  • microbubbles
  • molecular imaging
  • prostate cancer
  • ultrasound

ASJC Scopus subject areas

  • Acoustics and Ultrasonics

Cite this

Hoyt, K., Mahoney, M., & Sorace, A. G. (2014). Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer. In IEEE International Ultrasonics Symposium, IUS (pp. 1160-1163). [6931820] IEEE Computer Society. https://doi.org/10.1109/ULTSYM.2014.0285

Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer. / Hoyt, Kenneth; Mahoney, Marshall; Sorace, Anna G.

IEEE International Ultrasonics Symposium, IUS. IEEE Computer Society, 2014. p. 1160-1163 6931820.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Hoyt, K, Mahoney, M & Sorace, AG 2014, Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer. in IEEE International Ultrasonics Symposium, IUS., 6931820, IEEE Computer Society, pp. 1160-1163, 2014 IEEE International Ultrasonics Symposium, IUS 2014, Chicago, United States, 9/3/14. https://doi.org/10.1109/ULTSYM.2014.0285
Hoyt K, Mahoney M, Sorace AG. Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer. In IEEE International Ultrasonics Symposium, IUS. IEEE Computer Society. 2014. p. 1160-1163. 6931820 https://doi.org/10.1109/ULTSYM.2014.0285
Hoyt, Kenneth ; Mahoney, Marshall ; Sorace, Anna G. / Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer. IEEE International Ultrasonics Symposium, IUS. IEEE Computer Society, 2014. pp. 1160-1163
@inproceedings{c4e0a2fa8e364afaa4dd8e6e2e596747,
title = "Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer",
abstract = "This article evaluated volumetric molecular ultrasound (US) imaging with multi-targeted microbubble (MB) contrast agents for detection of angiogenic imaging biomarkers in a preclinical cancer model. Imaging was performed using a modified US system (Ultrasonix Medical Corp) equipped with a 4-dimensional (4D) transducer. Image processing software separated the US signal originating from intravascular MBs that were bound to the overexpressed targets from the freely circulating and unattached contrast agent. Molecular US imaging using targeted MBs was compared to results obtained using non-specific control MBs in the same prostate-cancer bearing mouse. Molecular US signals were significantly higher when imaging the targeted MBs versus imaging of control contrast agent (p < 0.001). Specifically, it was found that molecular US imaging of the targeted MB contrast agent produced a considerable mean intratumoral enhancement of 19.5 ± 2.2 dB. A significant inverse correlation was found between the molecular US signal and fractional tumor enhancement (ρ = -0.56, p = 0.02). This suggests that as the spatial distribution of the molecular US signal increases, the average intensity of the intratumoral reporter signal decreases. This finding could identify when the neovascularity is inadequate to meet the metabolic demands of the tumor, creating a strong angiogenic response. This high angiogenic response is typically found in aggressive cancers and during early stages of tumor growth. Therefore, molecular US imaging may improve US for the early detection of cancer and help distinguish indolent from aggressive disease.",
keywords = "angiogenesis, contrast agent, microbubbles, molecular imaging, prostate cancer, ultrasound",
author = "Kenneth Hoyt and Marshall Mahoney and Sorace, {Anna G.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1109/ULTSYM.2014.0285",
language = "English (US)",
pages = "1160--1163",
booktitle = "IEEE International Ultrasonics Symposium, IUS",
publisher = "IEEE Computer Society",

}

TY - GEN

T1 - Four-dimensional molecular ultrasound imaging of tumor angiogenesis in a preclinical animal model of prostate cancer

AU - Hoyt, Kenneth

AU - Mahoney, Marshall

AU - Sorace, Anna G.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - This article evaluated volumetric molecular ultrasound (US) imaging with multi-targeted microbubble (MB) contrast agents for detection of angiogenic imaging biomarkers in a preclinical cancer model. Imaging was performed using a modified US system (Ultrasonix Medical Corp) equipped with a 4-dimensional (4D) transducer. Image processing software separated the US signal originating from intravascular MBs that were bound to the overexpressed targets from the freely circulating and unattached contrast agent. Molecular US imaging using targeted MBs was compared to results obtained using non-specific control MBs in the same prostate-cancer bearing mouse. Molecular US signals were significantly higher when imaging the targeted MBs versus imaging of control contrast agent (p < 0.001). Specifically, it was found that molecular US imaging of the targeted MB contrast agent produced a considerable mean intratumoral enhancement of 19.5 ± 2.2 dB. A significant inverse correlation was found between the molecular US signal and fractional tumor enhancement (ρ = -0.56, p = 0.02). This suggests that as the spatial distribution of the molecular US signal increases, the average intensity of the intratumoral reporter signal decreases. This finding could identify when the neovascularity is inadequate to meet the metabolic demands of the tumor, creating a strong angiogenic response. This high angiogenic response is typically found in aggressive cancers and during early stages of tumor growth. Therefore, molecular US imaging may improve US for the early detection of cancer and help distinguish indolent from aggressive disease.

AB - This article evaluated volumetric molecular ultrasound (US) imaging with multi-targeted microbubble (MB) contrast agents for detection of angiogenic imaging biomarkers in a preclinical cancer model. Imaging was performed using a modified US system (Ultrasonix Medical Corp) equipped with a 4-dimensional (4D) transducer. Image processing software separated the US signal originating from intravascular MBs that were bound to the overexpressed targets from the freely circulating and unattached contrast agent. Molecular US imaging using targeted MBs was compared to results obtained using non-specific control MBs in the same prostate-cancer bearing mouse. Molecular US signals were significantly higher when imaging the targeted MBs versus imaging of control contrast agent (p < 0.001). Specifically, it was found that molecular US imaging of the targeted MB contrast agent produced a considerable mean intratumoral enhancement of 19.5 ± 2.2 dB. A significant inverse correlation was found between the molecular US signal and fractional tumor enhancement (ρ = -0.56, p = 0.02). This suggests that as the spatial distribution of the molecular US signal increases, the average intensity of the intratumoral reporter signal decreases. This finding could identify when the neovascularity is inadequate to meet the metabolic demands of the tumor, creating a strong angiogenic response. This high angiogenic response is typically found in aggressive cancers and during early stages of tumor growth. Therefore, molecular US imaging may improve US for the early detection of cancer and help distinguish indolent from aggressive disease.

KW - angiogenesis

KW - contrast agent

KW - microbubbles

KW - molecular imaging

KW - prostate cancer

KW - ultrasound

UR - http://www.scopus.com/inward/record.url?scp=84910069842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910069842&partnerID=8YFLogxK

U2 - 10.1109/ULTSYM.2014.0285

DO - 10.1109/ULTSYM.2014.0285

M3 - Conference contribution

SP - 1160

EP - 1163

BT - IEEE International Ultrasonics Symposium, IUS

PB - IEEE Computer Society

ER -